Alume Biosciences Announces First Patient Dosed with ALM-488 in Phase 3 Pivotal Study in Patients Undergoing Head and Neck Surgery

/PRNewswire/ -- Alume Biosciences, Inc, a leader in the field of nerve-targeted diagnostics and therapeutics, today announced that the first patient has been...

Related Keywords

San Diego ,California ,United States ,Alume Biosciences ,Brett Berman ,University Of Pennsylvania ,Prnewswire Alume Biosciences Inc ,Neck Surgery ,Karthik Rajasekaran ,Johnson Innovation ,